Amy Reeves
Net worth: 2 123 $ as of 30/04/2024
Profile
Amy S.
Reeves worked as the Global Controller at Wright Medical Group NV from 2019 to 2021.
She then became the Chief Financial Officer at View, Inc. in 2021, where she will work until 2024.
Reeves received both undergraduate and graduate degrees from the University of Mississippi.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
VIEW INC. CLASS A
0.33% | 08/01/2024 | 13,270 ( 0.33% ) | 2 123 $ | 30/04/2024 |
Former positions of Amy Reeves
Companies | Position | End |
---|---|---|
VIEW, INC. | Director of Finance/CFO | 02/02/2024 |
WRIGHT MEDICAL GROUP N.V. | Comptroller/Controller/Auditor | 01/06/2021 |
Training of Amy Reeves
University of Mississippi | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
VIEW, INC. | Process Industries |
Private companies | 1 |
---|---|
Wright Medical Group NV
Wright Medical Group NV Medical SpecialtiesHealth Technology Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Amy Reeves